Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
50
ECOR Quote, Financials, Valuation and Earnings
Last price:
$6.78
Seasonality move
:
-20.97%
Day range:
$6.25 - $6.87
52-week range:
$4.16 - $8.64
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.75x
P/B ratio:
39.79x
Volume:
132K
Avg. volume:
67.1K
1-year change:
2.72%
Market cap:
$56.4M
Revenue:
$32M
EPS (TTM):
-$1.69
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ECOR
electroCore, Inc.
|
$9M | -- | 34.11% | -- | $19.80 |
|
ABT
Abbott Laboratories
|
$11B | $1.15 | 6.19% | 54.77% | $132.28 |
|
ARAY
Accuray, Inc.
|
$111.9M | -$0.05 | -1.19% | -296.83% | $2.53 |
|
ATEC
Alphatec Holdings, Inc.
|
$196.6M | -$0.00 | 16.23% | -99.65% | $24.42 |
|
BSX
Boston Scientific Corp.
|
$5.2B | $0.79 | 11.18% | 75.33% | $100.81 |
|
PSTV
Plus Therapeutics, Inc.
|
$974K | -$0.81 | -8.03% | -97.28% | $146.88 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ECOR
electroCore, Inc.
|
$6.80 | $19.80 | $56.4M | -- | $0.00 | 0% | 1.75x |
|
ABT
Abbott Laboratories
|
$102.87 | $132.28 | $179.6B | 27.81x | $0.63 | 2.32% | 4.08x |
|
ARAY
Accuray, Inc.
|
$0.42 | $2.53 | $52.3M | 149.00x | $0.00 | 0% | 0.11x |
|
ATEC
Alphatec Holdings, Inc.
|
$10.83 | $24.42 | $1.6B | -- | $0.00 | 0% | 2.05x |
|
BSX
Boston Scientific Corp.
|
$62.82 | $100.81 | $94.5B | 32.82x | $0.00 | 0% | 4.74x |
|
PSTV
Plus Therapeutics, Inc.
|
$3.56 | $146.88 | $22.3M | -- | $0.00 | 0% | 3.21x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ECOR
electroCore, Inc.
|
122.21% | -0.422 | 26.19% | 1.11x |
|
ABT
Abbott Laboratories
|
21.33% | 0.736 | 6.98% | 1.05x |
|
ARAY
Accuray, Inc.
|
76.53% | 3.369 | 177.87% | 0.52x |
|
ATEC
Alphatec Holdings, Inc.
|
94.3% | 1.812 | 18.94% | 1.24x |
|
BSX
Boston Scientific Corp.
|
33.07% | 1.671 | 8.45% | 0.94x |
|
PSTV
Plus Therapeutics, Inc.
|
17.04% | 1.919 | 1.16% | 1.09x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ECOR
electroCore, Inc.
|
$7.6M | -$2.9M | -162.38% | -681.93% | -31.82% | -$1.5M |
|
ABT
Abbott Laboratories
|
$6.1B | $2.4B | 10.13% | 12.91% | 20.68% | $2.6B |
|
ARAY
Accuray, Inc.
|
$24.1M | -$5.5M | -14.23% | -60.6% | -5.37% | -$21.6M |
|
ATEC
Alphatec Holdings, Inc.
|
$130.4M | -$5.4M | -23.65% | -1092.5% | -2.52% | $5.7M |
|
BSX
Boston Scientific Corp.
|
$3.6B | $1.2B | 8.3% | 12.55% | 22.93% | $1B |
|
PSTV
Plus Therapeutics, Inc.
|
$1.3M | -$5.7M | -- | -- | -420.04% | -$6.3M |
electroCore, Inc. vs. Competitors
-
Which has Higher Returns ECOR or ABT?
Abbott Laboratories has a net margin of -32.84% compared to electroCore, Inc.'s net margin of 15.71%. electroCore, Inc.'s return on equity of -681.93% beat Abbott Laboratories's return on equity of 12.91%.
Company Gross Margin Earnings Per Share Invested Capital ECORelectroCore, Inc.82.07% -$0.38 $7.7M ABTAbbott Laboratories53.5% $1.03 $66.9B -
What do Analysts Say About ECOR or ABT?
electroCore, Inc. has a consensus price target of $19.80, signalling upside risk potential of 191.18%. On the other hand Abbott Laboratories has an analysts' consensus of $132.28 which suggests that it could grow by 28.59%. Given that electroCore, Inc. has higher upside potential than Abbott Laboratories, analysts believe electroCore, Inc. is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings ECORelectroCore, Inc.4 0 0 ABTAbbott Laboratories16 7 0 -
Is ECOR or ABT More Risky?
electroCore, Inc. has a beta of 0.590, which suggesting that the stock is 40.952% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.787, suggesting its less volatile than the S&P 500 by 21.251%.
-
Which is a Better Dividend Stock ECOR or ABT?
electroCore, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 2.32% to investors and pays a quarterly dividend of $0.63 per share. electroCore, Inc. pays -- of its earnings as a dividend. Abbott Laboratories pays out 64.54% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ECOR or ABT?
electroCore, Inc. quarterly revenues are $9.2M, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. electroCore, Inc.'s net income of -$3M is lower than Abbott Laboratories's net income of $1.8B. Notably, electroCore, Inc.'s price-to-earnings ratio is -- while Abbott Laboratories's PE ratio is 27.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore, Inc. is 1.75x versus 4.08x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ECORelectroCore, Inc.1.75x -- $9.2M -$3M ABTAbbott Laboratories4.08x 27.81x $11.5B $1.8B
-
Which has Higher Returns ECOR or ARAY?
Accuray, Inc. has a net margin of -32.84% compared to electroCore, Inc.'s net margin of -13.47%. electroCore, Inc.'s return on equity of -681.93% beat Accuray, Inc.'s return on equity of -60.6%.
Company Gross Margin Earnings Per Share Invested Capital ECORelectroCore, Inc.82.07% -$0.38 $7.7M ARAYAccuray, Inc.23.54% -$0.11 $227.6M -
What do Analysts Say About ECOR or ARAY?
electroCore, Inc. has a consensus price target of $19.80, signalling upside risk potential of 191.18%. On the other hand Accuray, Inc. has an analysts' consensus of $2.53 which suggests that it could grow by 507.99%. Given that Accuray, Inc. has higher upside potential than electroCore, Inc., analysts believe Accuray, Inc. is more attractive than electroCore, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ECORelectroCore, Inc.4 0 0 ARAYAccuray, Inc.2 0 0 -
Is ECOR or ARAY More Risky?
electroCore, Inc. has a beta of 0.590, which suggesting that the stock is 40.952% less volatile than S&P 500. In comparison Accuray, Inc. has a beta of 1.317, suggesting its more volatile than the S&P 500 by 31.653%.
-
Which is a Better Dividend Stock ECOR or ARAY?
electroCore, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Accuray, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore, Inc. pays -- of its earnings as a dividend. Accuray, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ECOR or ARAY?
electroCore, Inc. quarterly revenues are $9.2M, which are smaller than Accuray, Inc. quarterly revenues of $102.2M. electroCore, Inc.'s net income of -$3M is higher than Accuray, Inc.'s net income of -$13.8M. Notably, electroCore, Inc.'s price-to-earnings ratio is -- while Accuray, Inc.'s PE ratio is 149.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore, Inc. is 1.75x versus 0.11x for Accuray, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ECORelectroCore, Inc.1.75x -- $9.2M -$3M ARAYAccuray, Inc.0.11x 149.00x $102.2M -$13.8M
-
Which has Higher Returns ECOR or ATEC?
Alphatec Holdings, Inc. has a net margin of -32.84% compared to electroCore, Inc.'s net margin of -10.21%. electroCore, Inc.'s return on equity of -681.93% beat Alphatec Holdings, Inc.'s return on equity of -1092.5%.
Company Gross Margin Earnings Per Share Invested Capital ECORelectroCore, Inc.82.07% -$0.38 $7.7M ATECAlphatec Holdings, Inc.61.24% -$0.14 $632.1M -
What do Analysts Say About ECOR or ATEC?
electroCore, Inc. has a consensus price target of $19.80, signalling upside risk potential of 191.18%. On the other hand Alphatec Holdings, Inc. has an analysts' consensus of $24.42 which suggests that it could grow by 125.45%. Given that electroCore, Inc. has higher upside potential than Alphatec Holdings, Inc., analysts believe electroCore, Inc. is more attractive than Alphatec Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ECORelectroCore, Inc.4 0 0 ATECAlphatec Holdings, Inc.8 0 0 -
Is ECOR or ATEC More Risky?
electroCore, Inc. has a beta of 0.590, which suggesting that the stock is 40.952% less volatile than S&P 500. In comparison Alphatec Holdings, Inc. has a beta of 1.117, suggesting its more volatile than the S&P 500 by 11.658%.
-
Which is a Better Dividend Stock ECOR or ATEC?
electroCore, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore, Inc. pays -- of its earnings as a dividend. Alphatec Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ECOR or ATEC?
electroCore, Inc. quarterly revenues are $9.2M, which are smaller than Alphatec Holdings, Inc. quarterly revenues of $212.9M. electroCore, Inc.'s net income of -$3M is higher than Alphatec Holdings, Inc.'s net income of -$21.7M. Notably, electroCore, Inc.'s price-to-earnings ratio is -- while Alphatec Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore, Inc. is 1.75x versus 2.05x for Alphatec Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ECORelectroCore, Inc.1.75x -- $9.2M -$3M ATECAlphatec Holdings, Inc.2.05x -- $212.9M -$21.7M
-
Which has Higher Returns ECOR or BSX?
Boston Scientific Corp. has a net margin of -32.84% compared to electroCore, Inc.'s net margin of 12.68%. electroCore, Inc.'s return on equity of -681.93% beat Boston Scientific Corp.'s return on equity of 12.55%.
Company Gross Margin Earnings Per Share Invested Capital ECORelectroCore, Inc.82.07% -$0.38 $7.7M BSXBoston Scientific Corp.68.5% $0.45 $36.4B -
What do Analysts Say About ECOR or BSX?
electroCore, Inc. has a consensus price target of $19.80, signalling upside risk potential of 191.18%. On the other hand Boston Scientific Corp. has an analysts' consensus of $100.81 which suggests that it could grow by 60.48%. Given that electroCore, Inc. has higher upside potential than Boston Scientific Corp., analysts believe electroCore, Inc. is more attractive than Boston Scientific Corp..
Company Buy Ratings Hold Ratings Sell Ratings ECORelectroCore, Inc.4 0 0 BSXBoston Scientific Corp.24 0 0 -
Is ECOR or BSX More Risky?
electroCore, Inc. has a beta of 0.590, which suggesting that the stock is 40.952% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.781, suggesting its less volatile than the S&P 500 by 21.926%.
-
Which is a Better Dividend Stock ECOR or BSX?
electroCore, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore, Inc. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ECOR or BSX?
electroCore, Inc. quarterly revenues are $9.2M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. electroCore, Inc.'s net income of -$3M is lower than Boston Scientific Corp.'s net income of $670M. Notably, electroCore, Inc.'s price-to-earnings ratio is -- while Boston Scientific Corp.'s PE ratio is 32.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore, Inc. is 1.75x versus 4.74x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ECORelectroCore, Inc.1.75x -- $9.2M -$3M BSXBoston Scientific Corp.4.74x 32.82x $5.3B $670M
-
Which has Higher Returns ECOR or PSTV?
Plus Therapeutics, Inc. has a net margin of -32.84% compared to electroCore, Inc.'s net margin of -417.92%. electroCore, Inc.'s return on equity of -681.93% beat Plus Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ECORelectroCore, Inc.82.07% -$0.38 $7.7M PSTVPlus Therapeutics, Inc.93.27% -$0.04 $4.8M -
What do Analysts Say About ECOR or PSTV?
electroCore, Inc. has a consensus price target of $19.80, signalling upside risk potential of 191.18%. On the other hand Plus Therapeutics, Inc. has an analysts' consensus of $146.88 which suggests that it could grow by 4025.7%. Given that Plus Therapeutics, Inc. has higher upside potential than electroCore, Inc., analysts believe Plus Therapeutics, Inc. is more attractive than electroCore, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ECORelectroCore, Inc.4 0 0 PSTVPlus Therapeutics, Inc.3 1 0 -
Is ECOR or PSTV More Risky?
electroCore, Inc. has a beta of 0.590, which suggesting that the stock is 40.952% less volatile than S&P 500. In comparison Plus Therapeutics, Inc. has a beta of 1.025, suggesting its more volatile than the S&P 500 by 2.509%.
-
Which is a Better Dividend Stock ECOR or PSTV?
electroCore, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore, Inc. pays -- of its earnings as a dividend. Plus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ECOR or PSTV?
electroCore, Inc. quarterly revenues are $9.2M, which are larger than Plus Therapeutics, Inc. quarterly revenues of $1.4M. electroCore, Inc.'s net income of -$3M is higher than Plus Therapeutics, Inc.'s net income of -$5.7M. Notably, electroCore, Inc.'s price-to-earnings ratio is -- while Plus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore, Inc. is 1.75x versus 3.21x for Plus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ECORelectroCore, Inc.1.75x -- $9.2M -$3M PSTVPlus Therapeutics, Inc.3.21x -- $1.4M -$5.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 3
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 3
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 3
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
